Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery-Reference-Cited by-同舟云学术

Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery

Published:2019-03-18 Issue:8 Volume:91 Page:5433-5445
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Li Qiongyu¹^ORCID,Kailemia Muchena J.¹^ORCID,Merleev Alexander A.²,Xu Gege³^ORCID,Serie Daniel³,Danan Lieza M.³,Haj Fawaz G.⁴⁵,Maverakis Emanual²,Lebrilla Carlito B.¹^ORCID

Affiliation:

1. Department of Chemistry, University of California, One Shields Avenue, Davis, California 95616, United States

2. Department of Dermatology, University of California Davis, School of Medicine, Sacramento, California 95817, United States

3. Venn Biosciences Corporation, 800 Chesapeake Dr., Redwood City, California 94063, United States

4. Department of Nutrition, University of California, One Shields Avenue, Davis, California 95616, United States

5. Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of California Davis, Sacramento, California 95817, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of General Medical Sciences

National Institute of Environmental Health Sciences

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.9b00776

Reference34 articles.

1. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges